Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Trials
|
April 12, 2024
Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation
Emma McNaught, Sophie Reale, Liam Bourke, et al.
Health Technology Assessment (Winchester, England)
|
March 23, 2021
Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCT
David G Jayne, Annabelle E Williams, Neil Corrigan, et al.
BMJ Open
|
March 25, 2018
Improving the management of pain from advanced cancer in the community: study protocol for a pragmatic multicentre randomised controlled trial
Matthew J Allsop, Alexandra Wright-Hughes, Kath Black, et al.
BMC Cancer
|
July 2, 2021
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
Oliver Coen, Pippa Corrie, Helen Marshall, et al.
Trials
|
June 26, 2016
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial
Claire A Surr, Rebecca E A Walwyn, Amanda Lilley-Kelly, et al.
BMJ Open
|
June 2, 2022
<i>F</i>railty-adjusted therapy <i>i</i>n <i>T</i>ransplant <i>N</i>on-<i>E</i>ligible patient<i>s</i> with newly diagno<i>s</i>ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial
Amy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, et al.
The Lancet. Oncology
|
November 1, 2019
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
Mark T Drayson, Stella Bowcock, Tim Planche, et al.
British Journal of Haematology
|
March 30, 2026
Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximab
David J Allsup, David A Cairns, E Faye Samy, et al.
BMJ Open
|
November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
Kara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Aging & Mental Health
|
April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial
Claire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Trials
|
April 12, 2024
Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation
Emma McNaught, Sophie Reale, Liam Bourke, et al.
Health Technology Assessment (Winchester, England)
|
March 23, 2021
Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCT
David G Jayne, Annabelle E Williams, Neil Corrigan, et al.
BMJ Open
|
March 25, 2018
Improving the management of pain from advanced cancer in the community: study protocol for a pragmatic multicentre randomised controlled trial
Matthew J Allsop, Alexandra Wright-Hughes, Kath Black, et al.
BMC Cancer
|
July 2, 2021
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
Oliver Coen, Pippa Corrie, Helen Marshall, et al.
Trials
|
June 26, 2016
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial
Claire A Surr, Rebecca E A Walwyn, Amanda Lilley-Kelly, et al.
BMJ Open
|
June 2, 2022
<i>F</i>railty-adjusted therapy <i>i</i>n <i>T</i>ransplant <i>N</i>on-<i>E</i>ligible patient<i>s</i> with newly diagno<i>s</i>ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial
Amy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, et al.
The Lancet. Oncology
|
November 1, 2019
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
Mark T Drayson, Stella Bowcock, Tim Planche, et al.
British Journal of Haematology
|
March 30, 2026
Patient-reported health-related quality of life in previously untreated chronic lymphocytic leukaemia: Results from the randomised phase 3 FLAIR trial comparing ibrutinib-rituximab versus fludarabine-cyclophosphamide-rituximab
David J Allsup, David A Cairns, E Faye Samy, et al.
BMJ Open
|
November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial
Kara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Aging & Mental Health
|
April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial
Claire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.
Page
of 10